Michael E. Lassman, Ph.D., is a Principle Scientist in the Clinical Development Laboratory at Merck Research Laboratories, Rahway NJ. He is responsible for the development and implementation of biomarker assays to support experimental medicine and early phase clinical trials. His responsibilities include developing clinical protocols to measure biomarkers associated with all disease areas at Merck.